戻る
「早戻しボタン」を押すと検索画面に戻ります。

今後説明を表示しない

[OK]

コーパス検索結果 (1語後でソート)

通し番号をクリックするとPubMedの該当ページを表示します
1  (n = 3) of those without LGE (p < 0.001 for Kaplan-Meier survival curves).
2 tiglaucoma medications, time to failure, and Kaplan-Meier survival curve.
3 lmic slit-lamp biomicroscopy and analyzed by Kaplan-Meier survival curve.
4 imately 4 mo) than FVB mice evaluated by the Kaplan-Meier survival curve.
5 ion-free survival rates were estimated using Kaplan-Meier survival curves.
6 ting-characteristic (ROC) curve analysis and Kaplan-Meier survival curves.
7 e mortality was calculated from standardized Kaplan-Meier survival curves.
8 y were also determined by comparing adjusted Kaplan-Meier survival curves.
9                 Univariate analysis included Kaplan-Meier survival curves.
10 by using Cox proportional hazards models and Kaplan-Meier survival curves.
11 eriod and graft survival was evaluated using Kaplan-Meier survival curves.
12 is ability remained strong on time-dependent Kaplan-Meier survival curves.
13   The log-rank procedure was used to compare Kaplan-Meier survival curves.
14 ferences were tested by log-rank tests using Kaplan-Meier survival curves.
15 e than 1.27 (high risk) was used to stratify Kaplan-Meier survival curves.
16  1-hour survival were analyzed with chi2 and Kaplan-Meier survival curves.
17                                              Kaplan-Meier survival curve analysis revealed that wild-
18 my), or a sham operation (controls) by using Kaplan-Meier survival curve analysis.
19                                            A Kaplan-Meier survival curve and log-rank test were used
20  analysis, investigators often present crude Kaplan-Meier survival curves and adjusted relative hazar
21                                              Kaplan-Meier survival curves and area under the receiver
22 were compared between these two groups using Kaplan-Meier survival curves and Cox proportional hazard
23            Graft survival was analyzed using Kaplan-Meier survival curves and Cox regression analysis
24                                              Kaplan-Meier survival curves and Cox regression models w
25 mission after CAS compared with CEA, we used Kaplan-Meier survival curves and fitted mixed-effects lo
26                                              Kaplan-Meier survival curves and log-rank tests revealed
27 f AF on outcomes was evaluated by unadjusted Kaplan-Meier survival curves and logistic regression mod
28 bgroups defined by these measurements, using Kaplan-Meier survival curves and multivariate Cox propor
29                                 We generated Kaplan-Meier survival curves and performed a multivariab
30  We used standard survival methods including Kaplan-Meier survival curves and sex-by-treatment intera
31 high-grade rejection within 90 days by chi2, Kaplan Meier survival curves, and by multivariable logis
32    Catheter patency was described by using a Kaplan-Meier survival curve, and number of catheter days
33 tistical analysis included chi-square tests, Kaplan-Meier survival curves, and Cox proportional-hazar
34 vival using Cox proportional hazards models, Kaplan-Meier survival curves, and the log-rank test.
35     Descriptive statistics, incidence rates, Kaplan-Meier survival curves, and the RR of NLP outcomes
36 US cancer population using an area under the Kaplan-Meier survival curve approach that combined trial
37 roportional survival hazards and plotted the Kaplan-Meier survival curves as well as the net chance o
38                                              Kaplan-Meier survival curves assessed the timing of init
39 nd outcome of pneumococcal meningitis, using Kaplan-Meier survival curves, bacteriological and histol
40                                              Kaplan-Meier survival curves compared time to death for
41 as allograft survival is represented using a Kaplan-Meier survival curve comparing (1) locally procur
42                        Data were analyzed by Kaplan-Meier survival curves, Cox regression, and binary
43                                          The Kaplan-Meier survival curves differed significantly for
44 ermanent ventilation was not reached and the Kaplan-Meier survival curve diverged from a published na
45                                              Kaplan-Meier survival curves estimated the time from ini
46 x proportional hazards model, log-rank test, Kaplan-Meier survival curve, Fisher exact test, and t te
47 s to develop a mathematical model to predict Kaplan-Meier survival curves for chemotherapy combined w
48                                              Kaplan-Meier survival curves for each cohort were not si
49                                              Kaplan-Meier survival curves for overall survival showed
50                                              Kaplan-Meier survival curves for the 2 procedures were c
51 eflected in good separation of tertile-based Kaplan-Meier survival curves for these variables.
52                                              Kaplan-Meier survival curves indicated a 33% 5-year surv
53 pression (odds ratio 7.17 [95% CI 1.5-34.5]; Kaplan-Meier survival curve, log-rank statistic 9.11 [p=
54                           Analyses included: Kaplan-Meier survival curves, Log-Rank tests, and Cox pr
55            Survival data were analyzed using Kaplan-Meier survival curves, log-rank tests, and propor
56                                              Kaplan-Meier survival curves, log-rank tests, and Weibul
57                                              Kaplan-Meier survival curves of MDI-based risk classes s
58 ay graphic technique was used to compare the Kaplan-Meier survival curves of patients with local recu
59 ffected by identified variables, we compared Kaplan-Meier survival curves of transplanted and control
60 ost previous studies contrasted (unadjusted) Kaplan-Meier survival curves or, if covariate-adjusted,
61  of a lethal dose of B. dermatitidis yeasts (Kaplan-Meier survival curve P values of 0.027 to 0.0002)
62              Observed median survival times, Kaplan-Meier survival curves, proportional death hazard
63                                              Kaplan-Meier survival curves rapidly declined with incre
64                                              Kaplan-Meier survival curves, results of log rank tests,
65                                     Adjusted Kaplan-Meier survival curves revealed that at any point
66                                              Kaplan-Meier survival curves showed better survival in P
67 ues of 34 mL/m(2) for LAVI and -15% for GLS, Kaplan-Meier survival curves showed significant better s
68                                              Kaplan-Meier survival curves showed that the uninsured g
69                                              Kaplan-Meier survival curves showed that these events oc
70                                              Kaplan-Meier survival curves showed the 20-30-year-old a
71                               In that study, Kaplan-Meier survival curves suggested worse cardiovascu
72                                      We used Kaplan-Meier survival curves to display the time to join
73 val rate as assessed by log rank analyses of Kaplan-Meier survival curves was significantly lower for
74                                              Kaplan Meier survival curves were analyzed with the log
75                                              Kaplan-Meier survival curves were also compared after st
76                                              Kaplan-Meier survival curves were also generated.
77 he occurrence of a cardiovascular event, and Kaplan-Meier survival curves were calculated.
78                                              Kaplan-Meier survival curves were compared with the two-
79                                              Kaplan-Meier survival curves were computed for risk scor
80                                              Kaplan-Meier survival curves were constructed and multiv
81                                              Kaplan-Meier survival curves were constructed to assess
82                                              Kaplan-Meier survival curves were constructed to depict
83                                              Kaplan-Meier survival curves were constructed using mean
84                                              Kaplan-Meier survival curves were constructed, and Cox p
85                                              Kaplan-Meier survival curves were drawn for midterm outc
86                                              Kaplan-Meier survival curves were examined for differenc
87 os (HR), 95% confidence intervals (CIs), and Kaplan-Meier survival curves were generated by gender an
88                                              Kaplan-Meier survival curves were generated for each gen
89                                              Kaplan-Meier survival curves were obtained by the log-ra
90                                              Kaplan-Meier survival curves were plotted for renal allo
91                                              Kaplan-Meier survival curves were plotted to determine c
92                                              Kaplan-Meier survival curves were used to analyze the da
93                                              Kaplan-Meier survival curves were used to compare graft
94                                              Kaplan-Meier survival curves were used to estimate age-s
95 ox proportional hazard regression models and Kaplan-Meier survival curves were used to identify predi
96                                        Using Kaplan-Meier survival curves with log-rank tests, health

WebLSDに未収録の専門用語(用法)は "新規対訳" から投稿できます。